Breaking news: ScreenPoint Medical appoints new CEO Read News
We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.
CE marked and FDA cleared
Here’s a short introduction to what we do
Trusted in more than 25 countries
FDA cleared and CE marked for 2D and 3D mammography
The most independent peer reviewed publications in breast AI
Proven multivendor compatibility
Integrated with most workstations
Experience the benefit of our continuously evolving deep learning algorithm
Accuracy.
Workload Reduction.
Risk.
"Transpara has the potential to detect specific cancers earlier. I can think of 1-2 recent cases with calcifications, where Transpara detected a cancer earlier that was not easily visible on a mammogram."
"Transpara increases my confidence and efficiency going through a screening mammography session. I have more focus especially with the higher risk cases thanks to their Intuitive Triage software."
“I could see the potential benefits of using AI for my practice and for my patients and it was a real success. With each release, the Transpara algorithms are continually getting better and better. I use it all the time and won’t read another 3D mammogram without it!”
“Transpara may allow discriminating studies, which require more attention and selection of those, which may be handled with single reading for example. It may thus contribute significantly to both risk adapted screening and optimum assignment of resources."
"We are at the forefront of one of the first prospective studies with Transpara. As we will implement Transpara in a real-life screening setting in Ostergotland County, we aim to improve the quality of the breast cancer screening program while at the same time safely reduce the workload of breast radiologists."
Client undergoes mammogram
Transpara analyses mammogram scan
Radiologist reads with support from Transpara, increasing confidence in decision
Make more accurate and consistent decision
The team running the country’s largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous
Read moreIn a recent study, the Cancer Registry of Norway used over 120,000 screening examinations from a population-based program to assess potential
Read moreFollowing the success of the world’s leading AI Breast Care system, Transpara®, now in use across the US and in
Read moreScreenPoint Medical’s Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to
Read moreFollowing the success of the world’s leading AI Breast Care system, Transpara®, now in use across the US and in
Read moreIt follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities
Read more
